DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
NAFAMOSTAT MESILATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
NAFAMOSTAT MESILATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ULIPRISTAL
4
Small molecule
Approved
Unknown
Unknown
Leiomyoma; Myoma
Progesterone receptor modulator
ULIPRISTAL
×
Maximum Phase:
4
First Approval:
None
UNII:
6J5J15Q2X8
Molecule Type:
Small molecule
Molecular Formula:
C28H35NO3
Molecular Weight:
433.59
AlogP:
4.97
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
3.0
Source:
POTASSIUM PHOSPHATE, MONOBASIC
4
Small molecule
Approved
Unknown
Unknown
Hypophosphatemia
Unknown
POTASSIUM PHOSPHATE, MONOBASIC
×
Maximum Phase:
4
First Approval:
None
UNII:
4J9FJ0HL51
Molecule Type:
Small molecule
Molecular Formula:
H2KO4P
Molecular Weight:
136.08
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CHLORPHENOXAMINE
4
Small molecule
Approved
Unknown
Unknown
Hypersensitivity; Pruritus
Histamine H1 receptor antagonist
CHLORPHENOXAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
3UVD77BP8R
Molecule Type:
Small molecule
Molecular Formula:
C18H22ClNO
Molecular Weight:
303.83
AlogP:
4.18
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
6.0
Source:
CLEBOPRIDE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Dopamine D2 receptor antagonist
CLEBOPRIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
I0A84520Y9
Molecule Type:
Small molecule
Molecular Formula:
C20H24ClN3O2
Molecular Weight:
373.88
AlogP:
3.33
PSA:
67.59
HBD:
2.0
HBA:
#RotB:
5.0
Source:
MOXISYLYTE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases; Erectile Dysfunction
Adrenergic receptor alpha antagonist
MOXISYLYTE
×
Maximum Phase:
4
First Approval:
None
UNII:
PW8QYA7KI0
Molecule Type:
Small molecule
Molecular Formula:
C16H25NO3
Molecular Weight:
279.38
AlogP:
2.98
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
6.0
Source:
DILOXANIDE FUROATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DILOXANIDE FUROATE
×
Maximum Phase:
4
First Approval:
None
UNII:
YP4N72IW34
Molecule Type:
Small molecule
Molecular Formula:
C14H11Cl2NO4
Molecular Weight:
328.15
AlogP:
3.27
PSA:
59.75
HBD:
0.0
HBA:
#RotB:
4.0
Source:
XAMOTEROL
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Beta-1 adrenergic receptor partial agonist
XAMOTEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
7HE0JQL703
Molecule Type:
Small molecule
Molecular Formula:
C16H25N3O5
Molecular Weight:
339.39
AlogP:
-0.24
PSA:
103.29
HBD:
4.0
HBA:
#RotB:
8.0
Source:
CHLOROXYLENOL
4
Small molecule
Approved
Unknown
Unknown
Inflammation
Unknown
CHLOROXYLENOL
×
Maximum Phase:
4
First Approval:
None
UNII:
0F32U78V2Q
Molecule Type:
Small molecule
Molecular Formula:
C8H9ClO
Molecular Weight:
156.61
AlogP:
2.66
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
PEANUT OIL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PEANUT OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
5TL50QU0W4
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULFAGUANIDINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
SULFAGUANIDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
15XQ8043FN
Molecule Type:
Small molecule
Molecular Formula:
C7H10N4O2S
Molecular Weight:
214.25
AlogP:
-0.77
PSA:
124.56
HBD:
3.0
HBA:
#RotB:
2.0
Source:
XENON XE-127
4
Small molecule
Approved
OTHER
INHALATION
Unknown
Unknown
XENON XE-127
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DISTIGMINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Acetylcholinesterase inhibitor
DISTIGMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
T940307O7B
Molecule Type:
Small molecule
Molecular Formula:
C22H32N4O4+2
Molecular Weight:
416.52
AlogP:
2.46
PSA:
66.84
HBD:
0.0
HBA:
#RotB:
9.0
Source:
DOTHIEPIN
4
Small molecule
Unknown
Unknown
Unknown
Depressive Disorder
Norepinephrine transporter inhibitor
DOTHIEPIN
×
Maximum Phase:
4
First Approval:
None
UNII:
W13O82Z7HL
Molecule Type:
Small molecule
Molecular Formula:
C19H21NS
Molecular Weight:
295.45
AlogP:
4.68
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
3.0
Source:
AMPICILLIN/AMPICILLIN TRIHYDRATE
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
AMPICILLIN/AMPICILLIN TRIHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROMETHAZINE TEOCLATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PROMETHAZINE TEOCLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
S5PUP23U26
Molecule Type:
Small molecule
Molecular Formula:
C24H27ClN6O2S
Molecular Weight:
499.04
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CYCLIZINE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CYCLIZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
W0O1NHP4WE
Molecule Type:
Small molecule
Molecular Formula:
C18H23ClN2
Molecular Weight:
302.85
AlogP:
3.02
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
3.0
Source:
IODOHIPPURATE SODIUM I-123
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IODOHIPPURATE SODIUM I-123
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OXITRIPTAN
4
Small molecule
Approved
Unknown
Unknown
Depressive Disorder, Major; Obesity; Spinal Cord Injuries; Sleep Wake Disorders; Depressive Disorder
Unknown
OXITRIPTAN
×
Maximum Phase:
4
First Approval:
None
UNII:
C1LJO185Q9
Molecule Type:
Small molecule
Molecular Formula:
C11H12N2O3
Molecular Weight:
220.23
AlogP:
0.83
PSA:
99.34
HBD:
4.0
HBA:
#RotB:
3.0
Source:
NAFTAZONE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
NAFTAZONE
×
Maximum Phase:
4
First Approval:
None
UNII:
15B0523P5L
Molecule Type:
Small molecule
Molecular Formula:
C11H9N3O2
Molecular Weight:
215.21
AlogP:
0.92
PSA:
84.55
HBD:
2.0
HBA:
#RotB:
1.0
Source:
METILDIGOXIN
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
METILDIGOXIN
×
Maximum Phase:
4
First Approval:
None
UNII:
I7GG1YUC5V
Molecule Type:
Small molecule
Molecular Formula:
C42H66O14
Molecular Weight:
794.98
AlogP:
2.87
PSA:
192.06
HBD:
5.0
HBA:
#RotB:
8.0
Source:
SODIUM IODIDE I-123
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
SODIUM IODIDE I-123
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
185
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA